Intensity Therapeutics, Inc. Common stock (INTS) Institutional Ownership → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free INTS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS)CurrentInstitutional OwnershipPercentage3.74%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$8.81MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.33M Get INTS Insider Trade Alerts Want to know when executives and insiders are buying or selling Intensity Therapeutics, Inc. Common stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INTS Institutional Buying and Selling by Quarter Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Intensity Therapeutics, Inc. Common stock Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/26/2024 Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322% 4/23/2024 Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382% 2/9/2024 Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327% 2/6/2024 Sapient Capital LLC200,000$1.71M0.0%N/A1.459% 2/1/2024 Sigma Planning Corp34,443$295K0.0%-28.5%0.251% 1/29/2024 Sapient Capital LLC200,000$1.71M0.1%N/A1.459% 11/21/2023 Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360% 11/6/2023 Sigma Planning Corp48,144$191K0.0%N/A0.352% (Data available from 1/1/2016 forward) INTS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INTS shares? During the previous two years, the following institutional investors and hedge funds held shares of Intensity Therapeutics, Inc. Common stock shares: Sapient Capital LLC ($5.26M), Hohimer Wealth Management LLC ($384K), and Sigma Planning Corp ($295K), Mesirow Financial Investment Management Inc. ($230K).Learn more on INTS's institutional investors. What percentage of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors? 3.74% of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors. Learn more on INTS's institutional investor holdings. Which institutional investors have been buying Intensity Therapeutics, Inc. Common stock stock? The following institutional investors have purchased Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Sapient Capital LLC ($1.21M), Hohimer Wealth Management LLC ($186.46K), Sigma Planning Corp ($48.14K), and Mesirow Financial Investment Management Inc. ($44.18K). How much institutional buying is happening at Intensity Therapeutics, Inc. Common stock? Institutional investors have bought a total of 1,490,854 shares in the last 24 months. This purchase volume represents approximately $8.81M in transactions. Which Intensity Therapeutics, Inc. Common stock major shareholders have been selling company stock? The following institutional investors have sold Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Hohimer Wealth Management LLC ($141.69K), and Sigma Planning Corp ($13.70K). How much institutional selling is happening at Intensity Therapeutics, Inc. Common stock? Institutional investors have sold a total of 155,386 shares in the last 24 months. This volume of shares sold represents approximately $1.33M in transactions. Related Companies: AVRO Institutional Ownership CDTX Institutional Ownership GNTA Institutional Ownership ALGS Institutional Ownership LENZ Institutional Ownership QNCX Institutional Ownership TSBX Institutional Ownership OKYO Institutional Ownership CYTH Institutional Ownership IKNA Institutional Ownership This page (NASDAQ:INTS) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics, Inc. Common stock Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.